The Regenexx procedure utilizes expanded autologous mesenchymal stem cells for a variety of orthopedic conditions. Knee pain secondary to degenerative changes, post-surgical or trauma has been treated with The Regenexx procedure.
How successful is this therapy?
New data has been released and was posted on their website:
For 126 patients reporting and 29 patients that failed to respond (drop out rate of 23%). Approximately 75% of these patients were knee replacement candidates, 25% were knee surgery candidates to treat a solitary osteochondral lesion (micro fracture, ACI, MACI):
43.7% of patients are reporting better than 75% improvement.
Avoiding the risks associated with surgery and anaesthesia with no significant recovery time makes the use of cultured stem cell therapy attractive.